Pharmacogenomics in Older Adults
Nearly 400 FDA approved medications include pharmacogenomic information in their drug labeling, and greater than 90% of the population has a clinically actionable pharmacogenomic variant that can impact their medication outcomes. This continuing education webinar will identify medications used in older adults with data supporting the use of pharmacogenomic guided prescribing recommendations. Clinical pharmacogenomic practice guidelines will be reviewed and patient cases will be presented to demonstrate how pharmacogenomic data can help individualize pharmacotherapy in older adults.
Learning Objectives
At the conclusion of this application-based activity, participants should be able to:
- Identify medications commonly prescribed to older adults that have pharmacogenomic data in their drug labeling and clinical pharmacogenomics practice guidelines
- Analyze the relationships between genes and drugs commonly prescribed to older adults
- Apply the pharmacogenomic guided therapeutic recommendations outlined by clinical practice guidelines for medications used in older adults
Target Audience
Senior Care Pharmacists who provide expert advice on the use of medications to individuals and older adults and are committed to providing person-centered care, considering the complex interrelationships between disease states, nutrition, medications, and other variables.
Speaker
Lucas A. Berenbrok, PharmD, MS, BCACP
Associate Professor of Pharmacy & Therapeutics
University of Pittsburgh | School of Pharmacy
Financial Disclosure
Lucas Berenbrok does not have relevant financial relationships with ineligible companies.
None of the planners for this activity have relevant financial relationships to disclose with ineligible companies.
None of the planners for this activity have relevant financial relationships to disclose with ineligible companies.
How to Access Content
-
Select “launch” to open the course. Click through the menu items in sequence to move through the course process to claim credit. You must complete the course in its entirety to claim credit
-
Post-test be completed, with minimum score of 75%, before moving on to the evaluation.
-
All courses contain an evaluation that must be completed for full CPE credit by 01/15/2027, at 11:59pm ET. No exceptions or extensions permitted.
-
Once you have completed the course evaluation, please confirm proper submission by checking your CPE Monitor/and or BPS portal (BCGP pharmacists) within 24-48 hours of course completion.
-
If you need assistance, email the Education Department at
education@ascp.com
Claim Credit
UAN: 0203-9999-24-002-H01-P
Date of Release:02/01/2024 This activity took place, and was recorded on, 01/19/2024.
Participants who attended and complete the live webinar will not receive credit for this home-study version.
This CPE recertification activity will be published for twelve months.
Date of Expiration: 02/01/2025 11:59pm ET
Accreditation
ASCP is approved by BPS as a provider for the recertification of BCGP.
The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.